Literature DB >> 20576293

Cholesterol and triglycerides in antipsychotic-naive patients with nonaffective psychosis.

Brian Kirkpatrick1, Clemente Garcia-Rizo, Kun Tang, Emilio Fernandez-Egea, Miguel Bernardo.   

Abstract

Patients with psychosis have an increased prevalence of hyperlipidemia. We compared fasting concentrations of lipids in newly diagnosed, antipsychotic-naïve patients with nonaffective psychosis (N=87) and control subjects (N=92). After accounting for gender, age, smoking, socioeconomic status, and body mass index, there was no significant difference between the two groups in total cholesterol, high-density lipoproteins, low-density lipoproteins, or triglycerides. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20576293      PMCID: PMC4185193          DOI: 10.1016/j.psychres.2010.06.001

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  14 in total

Review 1.  Metabolic side effects of antipsychotic medication.

Authors:  A Tschoner; J Engl; M Laimer; S Kaser; M Rettenbacher; W W Fleischhacker; J R Patsch; C F Ebenbichler
Journal:  Int J Clin Pract       Date:  2007-08       Impact factor: 2.503

2.  Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness.

Authors:  S D Rosenberg; R E Drake; G L Wolford; K T Mueser; T E Oxman; R M Vidaver; K L Carrieri; R Luckoor
Journal:  Am J Psychiatry       Date:  1998-02       Impact factor: 18.112

3.  Association of schizophrenia with low maternal body mass index, small size at birth, and thinness during childhood.

Authors:  K Wahlbeck; T Forsén; C Osmond; D J Barker; J G Eriksson
Journal:  Arch Gen Psychiatry       Date:  2001-01

Review 4.  Insulin resistance and lipid metabolism.

Authors:  B V Howard
Journal:  Am J Cardiol       Date:  1999-07-08       Impact factor: 2.778

Review 5.  Lipid disorders in type 2 diabetes.

Authors:  L T Braun
Journal:  Nurs Clin North Am       Date:  2001-06       Impact factor: 1.208

Review 6.  The effects of antipsychotic therapy on serum lipids: a comprehensive review.

Authors:  Jonathan M Meyer; Carol E Koro
Journal:  Schizophr Res       Date:  2004-09-01       Impact factor: 4.939

7.  Metabolic risk factors in drug-naive patients with first-episode psychosis.

Authors:  Swapna K Verma; Mythily Subramaniam; Alvin Liew; Lye Yin Poon
Journal:  J Clin Psychiatry       Date:  2009-06-02       Impact factor: 4.384

Review 8.  Antipsychotic medications: metabolic and cardiovascular risk.

Authors:  John W Newcomer
Journal:  J Clin Psychiatry       Date:  2007       Impact factor: 4.384

Review 9.  A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?

Authors:  Sukanta Saha; David Chant; John McGrath
Journal:  Arch Gen Psychiatry       Date:  2007-10

10.  Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia.

Authors:  Martina C M Ryan; Patrick Collins; Jogin H Thakore
Journal:  Am J Psychiatry       Date:  2003-02       Impact factor: 18.112

View more
  1 in total

Review 1.  Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis.

Authors:  Toby Pillinger; Katherine Beck; Brendon Stubbs; Oliver D Howes
Journal:  Br J Psychiatry       Date:  2017-10-05       Impact factor: 9.319

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.